Christine Blank

FDA approves Jardiance and Synjardy for pediatric use.

A bipartisan Senate bill, Affordable Insulin Now Act of 2023, would require plans to cover insulin for no more than $35 per month.

The ads focus on how PBMs promote competition in the prescription drug marketplace and provide choice for employers.

Six tips for protecting yourself and your family during the pandemic